These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 20388846
21. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential. Zhang T, Sun HC, Xu Y, Zhang KZ, Wang L, Qin LX, Wu WZ, Liu YK, Ye SL, Tang ZY. Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8557-63. PubMed ID: 16361537 [Abstract] [Full Text] [Related]
29. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma. Ip WK, Lai PB, Wong NL, Sy SM, Beheshti B, Squire JA, Wong N. Cancer Lett; 2007 Jun 08; 250(2):284-91. PubMed ID: 17126992 [Abstract] [Full Text] [Related]
30. Genome-wide hypomethylation in hepatocellular carcinogenesis. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF. Cancer Res; 2001 May 15; 61(10):4238-43. PubMed ID: 11358850 [Abstract] [Full Text] [Related]
32. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y, Hu MY, Chen BH, Wang ZJ, Zha XL, Liu KD. Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):530-5. PubMed ID: 16681881 [Abstract] [Full Text] [Related]
33. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q. Br J Cancer; 1999 Nov 28; 81(5):814-21. PubMed ID: 10555751 [Abstract] [Full Text] [Related]
34. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Oncogene; 2006 Apr 20; 25(17):2537-45. PubMed ID: 16331254 [Abstract] [Full Text] [Related]
35. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Xu JY, Chen LB, Xu JY, Yang Z, Xu RH, Wei HY. Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):481-4. PubMed ID: 16772086 [Abstract] [Full Text] [Related]
36. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A. J Hepatol; 2010 Feb 01; 52(2):220-7. PubMed ID: 20036025 [Abstract] [Full Text] [Related]
37. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients. Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M. Ann Surg Oncol; 2006 Jul 01; 13(7):947-54. PubMed ID: 16788756 [Abstract] [Full Text] [Related]
38. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, Murakami Y, Kuroda M, Miyajima A, Kato T, Ochiya T. Biomarkers; 2009 Nov 01; 14(7):529-38. PubMed ID: 19863192 [Abstract] [Full Text] [Related]
39. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]. Wang WX, Leng XS, Peng JR, Mu DC, Wang Y, Zhu JY, Du RY, Chen WF. Zhonghua Wai Ke Za Zhi; 2003 Jul 01; 41(7):506-8. PubMed ID: 12921655 [Abstract] [Full Text] [Related]
40. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P. Cancer Res; 2004 Sep 01; 64(17):6058-64. PubMed ID: 15342387 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]